Prognostic Implications and Predictors of Mitral Regurgitancy Reduction After Transcatheter Aortic Valve Implantation
2024

Mitral Regurgitation Improvement After Aortic Valve Surgery

Sample size: 156 publication 10 minutes Evidence: moderate

Author Information

Author(s): Güney Murat Can, Süygün Hakan, Polat Melike, Ayhan Hüseyin, Keleş Telat, Turinay Ertop Zeynep Şeyma, Bozkurt Engin, Grazioli Valentina, Franzese Ilaria

Primary Institution: Medicana International Ankara Hospital, Department of Cardiology, Faculty of Medicine, Atılım University

Hypothesis

What factors predict improvement in mitral regurgitation after transcatheter aortic valve implantation?

Conclusion

Baseline echocardiographic parameters can predict mitral regurgitation improvement after transcatheter aortic valve implantation, but this improvement does not predict survival.

Supporting Evidence

  • 68% of patients showed MR reduction at 6 months.
  • 81% of patients showed MR reduction at 1 year.
  • Lower baseline LVEDD, LA, and LVMI were predictors of MR improvement.
  • Higher baseline EF levels were associated with better MR outcomes.
  • Baseline MR severity was linked to one-year mortality.
  • Patients with functional MR had better outcomes post-TAVI.
  • Study included a high prevalence of functional MR patients.
  • Identifying predictors of MR reduction can enhance patient management.

Takeaway

Doctors can tell if a patient's leaky heart valve will get better after surgery by looking at certain heart measurements before the operation.

Methodology

This was a retrospective cohort study analyzing data from patients with moderate to severe mitral regurgitation undergoing transcatheter aortic valve implantation.

Potential Biases

Potential for selection bias due to exclusion of patients with missing data.

Limitations

The study is retrospective, which may introduce selection bias, and lacks standardized echocardiographic evaluations.

Participant Demographics

Median age of 79 years, with 40.6% male and 59.4% female.

Statistical Information

P-Value

p = 0.002 for LVEDD, p = 0.024 for LA, p = 0.024 for LVMI, p = 0.047 for EF

Confidence Interval

95% CI: 1.112–1.628 for LVEDD, 95% CI: 1.015–1.237 for LA, 95% CI: 1.020–1.207 for LVMI, 95% CI: 1.007–2.871 for EF

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/medicina60122077

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication